Evidence map›Paper›PMID 39511408›Full record

ArticleOncogene2025

Profiling the cancer-prone microenvironment in a zebrafish model for MPNST.

Cheryl Cero, John S House, Vincenzo Verdi, Jordan L Ferguson, Dereje D Jima, Aubrie A Selmek, Olivia M Patania, Jennifer E Dwyer, Bih-Rong Wei, Dillon T Lloyd and 1 more

Abstract read
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Choosing the right animal model for sarcoma research.Cellular and molecular life sciences : CMLS · 2026
    Review
  2. Review
  3. Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cheryl Cero *Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
John S House *Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USA.ORCID 0000-0002-8447-7871
Vincenzo VerdiLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-7963-5732
Jordan L FergusonState Laboratory of Public Health, North Carolina Department of Health and Human Services, Raleigh, NC, USA.
Dereje D JimaCenter of Human Health and the Environment and Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA.
Aubrie A SelmekDepartment of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA.
Olivia M PataniaStageBio, Frederick, MD, USA.
Jennifer E DwyerLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Bih-Rong WeiLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Dillon T LloydBiostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USA.
Heather R ShiveLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. heather.shive@nih.gov.ORCID 0000-0001-9148-2591

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Andrew R. Binder · 2015 to 2026
$18.3M
Identification of genetic collaborators in cancer with a brca2-mutant zebrafish modelK01OD021419 · OD · OHIO STATE UNIVERSITY · PI SHIVE, HEATHER R. · 2016 to 2021
$731k
NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA016086NIEHS NIH HHS P30 ES025128NIH HHS K01 OD021419UNC | UNC-Chapel Hill | Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (UNC Lineberger Comprehensive Cancer Center) (1960) 2018-1123U.S. Department of Health & Human Services | National Institutes of Health (NIH) K01OD021419U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) Intramural Research ProgramU.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30CA016058U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30CA016086U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS) Intramural Research ProgramU.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS) P30ES025128
6 · The paper itself

Abstract

Microenvironmental contributions to soft tissue sarcoma progression are relatively undefined, particularly during sarcoma onset. Use of animal models to reveal these contributions is impeded by difficulties in discriminating between microenvironmental, precancerous, and cancer cells, and challenges in defining a precancerous microenvironment. We developed a zebrafish model that allows segregation of microenvironmental, precancerous, and cancerous cell populations by fluorescence-activated cell sorting. This model has high predilection for malignant peripheral nerve sheath tumor (MPNST), a type of soft tissue sarcoma that exhibits rapid, aggressive growth. Using RNA-seq, we profiled the transcriptomes of microenvironmental, precancerous, and cancer cells from our zebrafish MPNST model. We show broad activation of inflammation/immune-associated signaling networks, describe gene expression patterns that uniquely characterize the transition from precancerous to cancer ME, and identify macrophages as potential contributors to microenvironmental phenotypes. We identify conserved gene expression changes and candidate genes of interest by comparative genomics analysis of MPNST versus benign lesions in both humans and zebrafish. Finally, we functionally validate a candidate extracellular matrix protein, periostin (POSTN), in human MPNST. This work provides insight into how the microenvironment may regulate MPNST initiation and progression.

Indexed as

NeurofibrosarcomaTumor MicroenvironmentAnimalsCell Adhesion MoleculesDisease Models, AnimalGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMacrophagesTranscriptomeZebrafishCell Adhesion Molecules

Identifiers

PMID39511408
PMCPMC11725499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.